{"database": "lobbying", "table": "lobbying_filings_raw", "rows": [["7b034c38-e0f6-4ba2-bb56-c26b2fe8e24c", "Q3", 400693064, "RED+BLUE STRATEGIES", 194270, "EXPRESS SCRIPTS INC.", 2013, "third_quarter", "2013-10-16T12:11:58.917000-04:00", 60000.0, 0, 0, 0, "{\"url\": \"https://lda.senate.gov/api/v1/filings/7b034c38-e0f6-4ba2-bb56-c26b2fe8e24c/\", \"filing_uuid\": \"7b034c38-e0f6-4ba2-bb56-c26b2fe8e24c\", \"filing_type\": \"Q3\", \"filing_type_display\": \"3rd Quarter - Report\", \"filing_year\": 2013, \"filing_period\": \"third_quarter\", \"filing_period_display\": \"3rd Quarter (July 1 - Sep 30)\", \"filing_document_url\": \"https://lda.senate.gov/filings/public/filing/7b034c38-e0f6-4ba2-bb56-c26b2fe8e24c/print/\", \"filing_document_content_type\": \"text/html\", \"income\": \"60000.00\", \"expenses\": null, \"expenses_method\": null, \"expenses_method_display\": null, \"posted_by_name\": \"Melanie Nathanson, Partner\", \"dt_posted\": \"2013-10-16T12:11:58.917000-04:00\", \"termination_date\": null, \"registrant_country\": \"United States of America\", \"registrant_ppb_country\": null, \"registrant_address_1\": \"601 13th Street NW\", \"registrant_address_2\": \"11th Floor North\", \"registrant_different_address\": false, \"registrant_city\": \"Washington\", \"registrant_state\": \"DC\", \"registrant_zip\": \"20005\", \"registrant\": {\"id\": 400693064, \"url\": \"https://lda.senate.gov/api/v1/registrants/400693064/\", \"house_registrant_id\": null, \"name\": \"RED+BLUE STRATEGIES\", \"description\": \"Health Care Consulting\", \"address_1\": \"975 F St NW\", \"address_2\": \"Suite 550\", \"address_3\": null, \"address_4\": null, \"city\": \"Washington\", \"state\": \"DC\", \"state_display\": \"District of Columbia\", \"zip\": \"20004\", \"country\": \"US\", \"country_display\": \"United States of America\", \"ppb_country\": \"US\", \"ppb_country_display\": \"United States of America\", \"contact_name\": \"MELANIE NATHANSON\", \"contact_telephone\": \"+1 202-258-9381\", \"dt_updated\": \"2026-02-25T17:01:10.141217-05:00\"}, \"client\": {\"id\": 194270, \"url\": \"https://lda.senate.gov/api/v1/clients/194270/\", \"client_id\": 12, \"name\": \"EXPRESS SCRIPTS INC.\", \"general_description\": \"Pharmacy Benefit Manager\", \"client_government_entity\": false, \"client_self_select\": false, \"state\": \"DC\", \"state_display\": \"District of Columbia\", \"country\": \"US\", \"country_display\": \"United States of America\", \"ppb_state\": \"MO\", \"ppb_state_display\": \"Missouri\", \"ppb_country\": \"US\", \"ppb_country_display\": \"United States of America\", \"effective_date\": \"2011-01-14\"}, \"lobbying_activities\": [{\"general_issue_code\": \"HCR\", \"general_issue_code_display\": \"Health Issues\", \"description\": \"Implementation of the Health Reform Law with a focus on regulations related to the medical loss ratio (MLR), Accountable Care Organizations, Transparency, E-prescribing,  Health Information Technology, and Essential Health Benefits.\\n\\nH.R. 3204 - Drug Quality and Security Act - issues addressing secure pharmaceutical supply chain and drug compounding practices.S. Con Res. 8 - Senate Budget Resolution for FY 2014 - Issues related to Medicare Part D \\n\\nH. R. 1367 - FEHBP Prescription Drug Integrity, Transparency and Cost Savings Act- focus on legislation that would negatively impact individuals access to mail order pharmacy.\\n\\nIssues related regulations that have the potential to the survey of mail order and specialty pharmacies for Medicaid purposes included in proposed OPM-focused policies in the Administration's 2014 Budget related to the utilization of Pharmacy Benefit Managers.\\n\\nTriCare and mail order issues.\\n\\nPolicies related to stopping prescription medication diversion.\\n\\nIssues related to international naming policies for generic medications\\n\\nIssues related to the Medicare Call Letter which could impact mail order utilization in Medicare Part D\\n\\nACA-related regulations impacting new rules for Exchanges specific to the promulgation of the prescription drug benefits.\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 54544, \"prefix\": \"ms\", \"prefix_display\": \"MS.\", \"first_name\": \"MELANIE\", \"nickname\": null, \"middle_name\": \"JAN\", \"last_name\": \"NATHANSON\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 145382, \"prefix\": \"ms\", \"prefix_display\": \"MS.\", \"first_name\": \"MEGAN\", \"nickname\": null, \"middle_name\": \"HAUCK\", \"last_name\": \"MARSHALL\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}], \"government_entities\": [{\"id\": 136, \"name\": \"Centers For Medicare and Medicaid Services (CMS)\"}, {\"id\": 11, \"name\": \"Executive Office of the President (EOP)\"}, {\"id\": 34, \"name\": \"Health & Human Services, Dept of (HHS)\"}, {\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}]}, {\"general_issue_code\": \"MMM\", \"general_issue_code_display\": \"Medicare/Medicaid\", \"description\": \"Monitoring ongoing Medicare and Medicaid regulations and guidance related to prescription medications, PBMs and related entities.\\nMonitoring potential health-related offsets related to Medicare Part D, Exchange-based and Medicaid pharmacy benefits.\\nIssues related regulations that have the potential to the survey of mail order and specialty pharmacies for Medicaid purposes.Working with CMS on Medicaid guidance specifically related to individual state pharmacy programs.\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 54544, \"prefix\": \"ms\", \"prefix_display\": \"MS.\", \"first_name\": \"MELANIE\", \"nickname\": null, \"middle_name\": \"JAN\", \"last_name\": \"NATHANSON\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 145382, \"prefix\": \"ms\", \"prefix_display\": \"MS.\", \"first_name\": \"MEGAN\", \"nickname\": null, \"middle_name\": \"HAUCK\", \"last_name\": \"MARSHALL\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}], \"government_entities\": [{\"id\": 136, \"name\": \"Centers For Medicare and Medicaid Services (CMS)\"}, {\"id\": 11, \"name\": \"Executive Office of the President (EOP)\"}, {\"id\": 34, \"name\": \"Health & Human Services, Dept of (HHS)\"}, {\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}]}, {\"general_issue_code\": \"PHA\", \"general_issue_code_display\": \"Pharmacy\", \"description\": \"H.R. 1367 - FEHBP Prescription Drug Integrity, Transparency and Cost Savings Act - focused on policies that would negatively impact access to mail order pharmacy\\n\\nRules, regulations and guidance specific to prescription drug pricing, generic utilization and specialty pharmacy.Issues impacting PBMs in up coming health related legislation.\\n\\nPolicies related to stopping the diversion of prescription medications in the nation's drug supply chain.\\n\\nChanges in International Naming policies for generic medications.\\n\\nACA-related regulations impacting new rules for Exchanges specific to the promulgation of the prescription drug benefits.\\n\\nH.R. 3204 - The Drug Quality and Security Act. Legislation to address secure the pharmaceutical supply chain and drug compounding practices.\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 54544, \"prefix\": \"ms\", \"prefix_display\": \"MS.\", \"first_name\": \"MELANIE\", \"nickname\": null, \"middle_name\": \"JAN\", \"last_name\": \"NATHANSON\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 145382, \"prefix\": \"ms\", \"prefix_display\": \"MS.\", \"first_name\": \"MEGAN\", \"nickname\": null, \"middle_name\": \"HAUCK\", \"last_name\": \"MARSHALL\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}], \"government_entities\": [{\"id\": 136, \"name\": \"Centers For Medicare and Medicaid Services (CMS)\"}, {\"id\": 11, \"name\": \"Executive Office of the President (EOP)\"}, {\"id\": 34, \"name\": \"Health & Human Services, Dept of (HHS)\"}, {\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}]}], \"conviction_disclosures\": [], \"foreign_entities\": [], \"affiliated_organizations\": []}"]], "columns": ["filing_uuid", "filing_type", "registrant_id", "registrant_name", "client_id", "client_name", "filing_year", "filing_period", "received_date", "amount_reported", "is_amendment", "is_no_activity", "is_termination", "raw_json"], "primary_keys": ["filing_uuid"], "primary_key_values": ["7b034c38-e0f6-4ba2-bb56-c26b2fe8e24c"], "units": {}, "query_ms": 6.239566951990128, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}